10000 news items
Page 5 of 100
tmg7n3w22epjkywbr5j
20 Jun 24
control, including those set forth in the Risk Factors section of the Company's Annual Report on Form 10-K filed with the Securities and Exchange
bw8wynkv5b2pyt
JAZZ
20 Jun 24
Jazz Pharmaceuticals' Annual Report on Form 10-K for the year ended December 31
z83xzamy klk4n
JBL
20 Jun 24
such differences can be found in our Annual Report on Form 10-K for the fiscal year ended August 31, 2023 and our other filings with the Securities
wsn3gqk3m0az5ne2p9zxdo pxz21nwbkcp2m5ruh
HTZ
20 Jun 24
on Form 10-K for the year ended December 31, 2023, as filed with the U.S. Securities
lxctu9261qt ixfpol1klfok
AVXL
20 Jun 24
on Form 10-K filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only
v8n3cpajpnz8gzp692babmym24dfx frrgewwhh1agu9xw5
BG
20 Jun 24
.
You should refer to "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2023 filed
lcgx76ovolj3grhfoea wahetki6
OPRX
20 Jun 24
, and other risks summarized in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2023, its subsequent Quarterly Reports
cylhful1l058m6 f7as97am2s334ivizq
HLMN
20 Jun 24
that are included in the Company's filings with the Securities and Exchange Commission ("SEC"), including our Annual Report on Form 10-K for the year ended
z0hfrt3qucncyp88ghzfgpku85pll8vxl2v3
SABS
20 Jun 24
recent annual report on Form 10-K, subsequent quarterly reports on Form 10-Q, as may be amended or supplemented from time to time, and other filings
2oes6w2juyg2lb1dmevpqk9ag3tffo
AAWH
20 Jun 24
Annual Report on Form 10-K for the year ended December 31, 2023
6ofavp2vo2etuhresfbz7b6iqsq n2ax148gibpa7i
AAWH
20 Jun 24
in the Company's Annual Report on Form 10-K for the year ended December 31, 2023
xl1556 7i8ikw
IRDM
20 Jun 24
by the forward-looking statements include those factors listed under the caption "Risk Factors" in the Company's Form 10-K for the year ended
44r wckfj9b7d4k3y8j8jf7r
IRDM
20 Jun 24
by the forward-looking statements include those factors listed under the caption "Risk Factors" in the Company's Form 10-K for the year
l9e2uvpoazol8b02dnisfrhwaihkxf2vi79tuyxryreqsvhsitzwc5d6titr
ATAI
20 Jun 24
titled "Risk Factors" in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC"), as such factors may
v9b771103 fgz77e551
20 Jun 24
, 2020, the Company's Annual Report on Form 10-K for the year ended December 31, 2023, as amended, and the Company's other public filings, in each case
21iasg53qrc9xnmego6rmic0c2g4qsn362ao7ozutbf4w0n
HROW
20 Jun 24
fully described in Harrow's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K and its Quarterly Reports
xptls9u2ngm9ka4nks53lkgb8xl0guj nyylxyhydz86m6miplxu0th
NTRB
20 Jun 24
" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the Company's Form S-1, Form 10-K for the year ended January
spds2i2rkg22ocrjckxlhpkryy
HON
20 Jun 24
statements should be considered in light of the information included in this release, our Form 10-K and other filings with the Securities and Exchange
10a4usfkk7l91wk7zquxawx55d
DFLI
20 Jun 24
Forward-Looking Statements" in the Company's Annual Report on Form 10-K for the year ended December 31, 2023, and in the Company's
cbbw05x4kl7b8otx88xh 26dcef95eda
DRI
20 Jun 24
in the statements. The most significant of these uncertainties are described in Darden's Form 10-K, Form 10-Q and Form 8-K reports. These risks